Dec 10, 2024 8:00 am EST Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening
Dec 6, 2024 9:00 am EST VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering
Nov 14, 2024 4:10 pm EST VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update
Nov 8, 2024 8:00 am EST VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update
Oct 31, 2024 8:00 am EDT Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating
Oct 9, 2024 8:00 am EDT Volition to share new 'NETs in sepsis management' data insights at upcoming webinar
